Actively Recruiting
Evaluating Abbreviated Antithrombotic Therapy After PCI in Patients With Atrial Fibrillation and Acute Myocardial Infarction
Led by Chonnam National University Hospital · Updated on 2026-09-02
860
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the clinical outcomes of two antithrombotic treatments in patients with atrial fibrillation AF and acute myocardial infarction AMI who have undergone percutaneous coronary intervention PCI. The study compares direct oral anticoagulant DOAC monotherapy to dual antithrombotic therapy DAT that combines a DOAC with clopidogrel. This research addresses the need to balance reducing bleeding risk while managing ischemic events, focusing on a population where evidence for DOAC monotherapy after AMI is limited. Participants eligible for the study have AF requiring lifelong oral anticoagulation and have been treated for AMI with PCI at least six months prior. After screening, they will be randomly assigned to one of two groups the DAT group receiving apixaban, edoxaban, or rivaroxaban combined with clopidogrel, or the DOAC monotherapy group receiving one of these DOACs alone. Treatments are administered orally with specific dosages depending on the group. The study monitors outcomes over one year following the last patient enrollment. During the trial, participants will undergo evaluations to measure net adverse clinical events NACE, major bleeding, cardiac and cerebrovascular events, mortality, and other related outcomes. These assessments include clinical follow-up and safety monitoring over a year. The study team will track various cardiovascular events and bleeding rates to compare the two treatment approaches, with the total participation time extending through the primary completion and study completion dates.
CONDITIONS
Brief Title
Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI
Research Team
S
Seung Hun Lee, MD, PhD
J
Joon Ho Ahn, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here